Delta Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.9M | Buy |
103,446
+1,015
| +1% | +$27K | 0.26% | 47 |
|
|
2025
Q4 | $2.55M | Sell |
102,431
-2,522
| -2% | -$63.6K | 0.22% | 48 |
|
|
2025
Q3 | $2.67M | Buy |
104,953
+518
| +0.5% | +$12.8K | 0.23% | 48 |
|
|
2025
Q2 | $2.53M | Buy |
104,435
+603
| +0.6% | +$14.1K | 0.22% | 49 |
|
|
2025
Q1 | $2.63M | Buy |
103,832
+5,838
| +6% | +$153K | 0.25% | 48 |
|
|
2024
Q4 | $2.6M | Buy |
97,994
+13,361
| +16% | +$362K | 0.23% | 48 |
|
|
2024
Q3 | $2.45M | Buy |
84,633
+2,339
| +3% | +$68.2K | 0.21% | 50 |
|
|
2024
Q2 | $2.3M | Buy |
82,294
+13,017
| +19% | +$358K | 0.21% | 51 |
|
|
2024
Q1 | $1.92M | Buy |
69,277
+20,997
| +43% | +$583K | 0.17% | 53 |
|
|
2023
Q4 | $1.39M | Buy |
48,280
+7,862
| +19% | +$238K | 0.13% | 59 |
|
|
2023
Q3 | $1.34M | Buy |
40,418
+2,254
| +6% | +$79.7K | 0.14% | 58 |
|
|
2023
Q2 | $1.4M | Buy |
38,164
+568
| +2% | +$22.1K | 0.14% | 58 |
|
|
2023
Q1 | $1.53M | Buy |
37,596
+1,038
| +3% | +$44.8K | 0.16% | 56 |
|
|
2022
Q4 | $1.87M | Buy |
36,558
+1,050
| +3% | +$50.3K | 0.2% | 52 |
|
|
2022
Q3 | $1.55M | Buy |
35,508
+327
| +0.9% | +$15.9K | 0.19% | 56 |
|
|
2022
Q2 | $1.84M | Sell |
35,181
-413
| -1% | -$21K | 0.21% | 47 |
|
|
2022
Q1 | $1.84M | Sell |
35,594
-859
| -2% | -$44.6K | 0.18% | 49 |
|
|
2021
Q4 | $2.15M | Sell |
36,453
-356
| -1% | -$17.6K | 0.19% | 49 |
|
|
2021
Q3 | $1.58M | Sell |
36,809
-2,721
| -7% | -$121K | 0.15% | 50 |
|
|
2021
Q2 | $1.55M | Sell |
39,530
-206
| -0.5% | -$8.01K | 0.15% | 50 |
|
|
2021
Q1 | $1.44M | Sell |
39,736
-137
| -0.3% | -$4.86K | 0.15% | 51 |
|
|
2020
Q4 | $1.47M | Sell |
39,873
-1,779
| -4% | -$65.3K | 0.16% | 48 |
|
|
2020
Q3 | $1.45M | Buy |
41,652
+189
| +0.5% | +$6.63K | 0.17% | 48 |
|
|
2020
Q2 | $1.29M | Buy |
41,463
+1,087
| +3% | +$36.9K | 0.17% | 50 |
|
|
2020
Q1 | $1.25M | Sell |
40,376
-93
| -0.2% | -$3.17K | 0.2% | 48 |
|
|
2019
Q4 | $1.5M | Buy |
40,469
+313
| +0.8% | +$11.1K | 0.19% | 45 |
|
|
2019
Q3 | $1.37M | Buy |
40,156
+863
| +2% | +$31.4K | 0.18% | 48 |
|
|
2019
Q2 | $1.61M | Buy |
39,293
+621
| +2% | +$24.7K | 0.22% | 45 |
|
|
2019
Q1 | $1.56M | Sell |
38,672
-4,512
| -10% | -$181K | 0.22% | 44 |
|
|
2018
Q4 | $1.79M | Sell |
43,184
-653
| -1% | -$27.1K | 0.28% | 42 |
|
|
2018
Q3 | $1.83M | Sell |
43,837
-2,163
| -5% | -$83.3K | 0.24% | 44 |
|
|
2018
Q2 | $1.58M | Sell |
46,000
-595
| -1% | -$20.3K | 0.23% | 44 |
|
|
2018
Q1 | $1.57M | Sell |
46,595
-49
| -0.1% | -$1.69K | 0.23% | 45 |
|
|
2017
Q4 | $1.6M | Sell |
46,644
-87
| -0.2% | -$2.97K | 0.23% | 46 |
|
|
2017
Q3 | $1.58M | Buy |
46,731
+2,509
| +6% | +$80.6K | 0.24% | 47 |
|
|
2017
Q2 | $1.41M | Sell |
44,222
-3,154
| -7% | -$99.5K | 0.22% | 49 |
|
|
2017
Q1 | $1.54M | Buy |
47,376
+810
| +2% | +$25.5K | 0.24% | 47 |
|
|
2016
Q4 | $1.44M | Sell |
46,566
-447
| -1% | -$13.6K | 0.24% | 45 |
|
|
2016
Q3 | $1.51M | Buy |
47,013
+283
| +0.6% | +$9.46K | 0.26% | 45 |
|
|
2016
Q2 | $1.56M | Sell |
46,730
-237
| -0.5% | -$7.56K | 0.27% | 44 |
|
|
2016
Q1 | $1.32M | Buy |
46,967
+1,982
| +4% | +$56.6K | 0.23% | 49 |
|
|
2015
Q4 | $1.38M | Buy |
44,985
+1,022
| +2% | +$32.2K | 0.25% | 48 |
|
|
2015
Q3 | $1.31M | Buy |
43,963
+1,529
| +4% | +$49K | 0.26% | 45 |
|
|
2015
Q2 | $1.35M | Sell |
42,434
-1,208
| -3% | -$39.4K | 0.25% | 44 |
|
|
2015
Q1 | $1.44M | Sell |
43,642
-720
| -2% | -$22.9K | 0.27% | 44 |
|
|
2014
Q4 | $1.31M | Buy |
44,362
+985
| +2% | +$28.2K | 0.26% | 44 |
|
|
2014
Q3 | $1.22M | Buy |
43,377
+448
| +1% | +$12.6K | 0.25% | 48 |
|
|
2014
Q2 | $1.21M | Buy |
42,929
+1,101
| +3% | +$31.4K | 0.25% | 48 |
|
|
2014
Q1 | $1.27M | Sell |
41,828
-1,086
| -3% | -$32.4K | 0.28% | 46 |
|
|
2013
Q4 | $1.25M | Buy |
42,914
+722
| +2% | +$21K | 0.28% | 49 |
|
|
2013
Q3 | $1.15M | Buy |
42,192
+65
| +0.2% | +$1.77K | 0.28% | 48 |
|
|
2013
Q2 | $1.12M | Buy |
+42,127
| New | +$1.16M | 0.28% | 49 |
|
Other funds holding PFE
VCM
VPM
Delta Asset Management's PFE Position: Q1 2026 in Review
Delta Asset Management increased its Pfizer (PFE) stake by 0.99% in Q1 2026, buying an estimated $27K and bringing the position to 103,446 shares worth $2.9M. The position accounts for 0.26% of the portfolio, ranked #47.
Delta Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Delta Asset Management held 103,446 shares of Pfizer worth $2.9M as of Q1 2026.
- Delta Asset Management bought 1,015 Pfizer shares in Q1 2026, an estimated $27K.
- Pfizer made up 0.26% of Delta Asset Management's portfolio in Q1 2026, its #47 holding.
- Delta Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.